Search Results - "Zamotaeva, M. N."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    THE STUDY OF MORPHOLOGICAL CHANGES IN TARGET ORGANS IN RATS’ CHRONIC DOXORUBICINE-INDUCED HEART FAILURE AND IN THE CORRECTION BACKGROUND OF 3-OXYPYRIDINE WITH HEMISUCCINATE by Zamotaeva, M. N., Chairkin, I. N., Chairkina, N. V., Zaytseva, E. N., Pizhamova, V. V.

    “…Background. The study of morphological changes in the heart, lungs, liver on a model of chronic heart failure (doxorubicin-induced) in the experiment and on…”
    Get full text
    Journal Article
  2. 2

    Evaluation of the Possibility of Correction of Doxorubicin-Induced Chronic Heart Failure in the Experiment with 3-Hydroxypyridine Acetylcysteinate and 3-Hydroxypyridine Succinate by Zamotaeva, M. N., Inchina, V. I., Konorev, V. V., Kuznetsov, Yu. V., Kuz’michev, N. D.

    “…The possibility of correction of morphological changes in the myocardium and biochemical parameters of the blood with 3-hydroxypyridine acetylcysteinate in a…”
    Get full text
    Journal Article
  3. 3

    Efficiency of Structurally Different Antioxidants in Combined Myocardial Damage in Mice by Zamotaeva, M. N., Inchina, V. I., Chairkin, I. N.

    “…Cardioprotective effects of derivatives of 3-hydroxypyridine, benzimidazole, and a peptide substance were studied on the model of combined damage to the…”
    Get full text
    Journal Article
  4. 4

    Experimental Substantiation for the Use of Mexidol and 3-Hydroxypyridine Fumarate in Chronic Myocardial Injury by Zamotaeva, M. N., Chairkin, I. N., Inchina, V. I., Drozdov, I. A.

    “…We studied the cardioprotective properties of mexidol and 3-hydroxypyridine fumarate in rat model of chronic myocardial injury. We found that 3-hydroxypyridine…”
    Get full text
    Journal Article
  5. 5